This paper reviews recent statistical advances in HIV/AIDS therapy trials.
Our emphasis is on three emerging areas that address key challenges in AIDS
research: the determination of optimal treatment sequences, estimating eff
icacy of intended treatment, and inference for repeated measures with depen
dent censoring. A common theme of these topics is the use of observational
data within clinical trials to answer questions nor addressed by the conven
tional intent-to-treat analysis. We also give a brief overview of some rece
nt contributions to other topics relevant to AIDS clinical trials, includin
g modelling of treatment compliance data, modelling of repeated measures, a
nd group sequential testing.